Business
Press Release Apr 01 2025
Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 01, 2025, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Pantoprazole Sodium for Injection, 40 mg/vial (Single-Dose Vial)".
About this update from Alembic Pharmaceuticals Limited
[{"type":"text","content":" Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 01, 2025, titled \"Alembic Pharmaceuticals receives USFDA Final Approval for Pantoprazole Sodium for Injection, 40 mg/vial (Single-Dose Vial)\". View Attachment","length":402,"tagName":"div"}]